Why Nothing Moves Until a Licensed Thai Importer Is in Place

Thailand's Food Act treats the licensed local importer as a threshold requirement, not a paperwork formality that can be handled after the rest of the launch plan is in motion. The importer, more precisely the holder of an Orr.7 license, takes on obligations that run for the full commercial life of the product on the Thai market, not just the moment of customs clearance. Getting this structure right before selecting a partner shapes every decision that follows, including how much leverage that partner ends up holding over your own market access, and how quickly you could recover if that relationship ever changed.

What the Food Act actually requires

Section 14 of the Food Act B.E. 2522 (1979) establishes that no person may import food into Thailand for commercial purposes without a license. Section 15 governs how that license is obtained: the Orr.7, formally the License for Importation or Ordering of Food into the Kingdom, has to be held by a natural person or juristic person carrying a Thai commercial registration certificate (ทะเบียนพาณิชย์) and maintaining a place of business inside Thailand. A foreign manufacturer cannot hold this license directly, full stop. The Orr.7 sits with a Thai entity, and until that entity is appointed and its license issued, no product can move through Thai customs on a commercial basis, regardless of how far along the rest of the approval process is.

The license itself runs from its date of issue until 31 December of the third year from the year it was issued; an Orr.7 issued in 2024, for example, remains valid through 31 December 2027. Applications are filed through Thai FDA's e-Submission system, which requires a Digital Government Development Agency OPEN ID account to access.

The obligations do not end at customs clearance

Holding the license is not a one-time event that clears a shipment and then recedes into the background. The Orr.7 holder carries continuing obligations for as long as the product remains on sale in Thailand, and these responsibilities are substantive, not administrative.

GMP maintenance sits with the importer: if the manufacturing site's GMP certificate lapses at any point during the import relationship, the compliance consequence lands on the importer, not the manufacturer overseas. Label and formula compliance is another standing obligation; each imported lot has to conform to the formula and label Thai FDA actually approved, and the importer is responsible for verifying that fact directly rather than simply accepting the manufacturer's word for it. Import documentation has to be maintained on an ongoing basis, including the import permit, a Certificate of Analysis for every batch, customs clearance records, and product inspection records.

Any change to the approved product, its formula, or its label requires a fresh approval application filed in the importer's own name; the importer has no authority to implement a manufacturer's reformulation on the Thai market without that new Thai FDA approval in hand first. And when Thai FDA conducts market surveillance inspections, whether at the importer's own premises or at retail, the importer has to cooperate and produce records on request, which means the recordkeeping obligations above are not optional busywork but the actual basis for passing an inspection.

The structural risk that shows up years after launch

The most consequential long-term risk in the Orr.7 structure has nothing to do with the initial application and everything to do with what happens if the importer relationship ends. The license does not transfer automatically to a new importer. A replacement importer has to apply for its own fresh Orr.7, and because the underlying product approval is tied to the original importer's specific details, the label approval itself will need to be updated to reflect the new importer's name and address before the product can legally move again. That update process takes real time, and during it, the product cannot legally be imported or sold in Thailand at all.

A foreign manufacturer that appoints its own Thai distribution partner as the Orr.7 holder has, whether or not this was the intent, handed that distributor real leverage over the manufacturer's own market access. If the commercial relationship sours, the path to appointing a replacement importer is slow and legally constrained, and the manufacturer has very little room to move quickly. The cleaner structure, and the one that protects the manufacturer's own position, is a neutral third-party importer entity that holds the license independently of whatever distribution relationship exists on the commercial side.

Why the importer question should be settled before formula finalization

Manufacturers sometimes treat the importer appointment as a downstream commercial task, something to sort out once the product formula and packaging are already locked and the brand is simply looking for a distribution partner. This ordering creates avoidable friction, because the product approval application itself is filed in the importer's name, and the label has to display that importer's Thai name and address as one of its mandatory elements. A manufacturer that finalizes its label artwork before the importer question is settled risks having to redo that artwork once the actual importer entity is confirmed, on top of whatever other changes emerge during the approval process itself.

There is also a practical negotiating dimension worth naming directly. A distribution partner that already knows it will hold the Orr.7 license has less incentive to negotiate commercial terms aggressively during the initial relationship, since the manufacturer's dependency on that partner for continued market access is baked in from day one. Settling the importer structure independently of the commercial distribution negotiation, and doing so before either agreement is signed, gives a foreign manufacturer materially more leverage in both conversations than treating the two as a single bundled decision.

Structuring importer selection before it becomes a dependency

For manufacturers without an existing Thai entity, the practical path is establishing and operating a licensed importer role that is deliberately kept separate from the distribution relationship, so market access never depends on the health of a single commercial partnership. For manufacturers who already have an importer relationship in place, the useful exercise is reviewing whether that existing structure genuinely protects market access or has quietly created a dependency that should be addressed before more products get registered under it. DeeMED Consulting structures and operates the Orr.7 licensed importer role for foreign supplement brands as part of our Thai FDA supplement import license services, keeping product registration independent of any single distribution relationship.